New Drug Development & Regulatory News
Qureight announces first results from collab with Insilico Medicine
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
16 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Trade win unlocks £250 million in exports for British pharma firms in Vietnam
British pharmaceutical companies are set to gain up to £250 million over the next five years as part of a Vietnamese law change that makes it easier to sell UK-made medicines to the country.
14 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Biotech founded by ex-Novo reseacher raises capital for oral obesity treatment
The biotech company, Pila Pharma, is raising 20 million Swedish kronor in an almost fully covered capital raise, which includes a stock option for future use.
8 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Biocon Biologics receives MHRA UK approval
Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the UK for Vevzuo and Evfraxy.
7 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Shift Bioscience proposes improved ranking system for virtual cell models
Shift Bioscience (Shift), a company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the results of a study detailing an improved approach to ranking virtual cell models for gene discovery.
2 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Rare disease biotech announces milestone
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
13 Jun 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Qureight announces first results from collab with Insilico Medicine
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
16 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Antares Vision Group and LedgerDomain announce strategic partnership
Antares Vision Group has announced a strategic partnership with LedgerDomain, a specialist in secure digital identity and credentialing for the healthcare supply chain.
15 Jul 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Trade win unlocks £250 million in exports for British pharma firms in Vietnam
British pharmaceutical companies are set to gain up to £250 million over the next five years as part of a Vietnamese law change that makes it easier to sell UK-made medicines to the country.
14 Jul 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Numan raises $60m to lead the next era of preventative digital healthcare
Numan, a UK digital health provider, has announced that it has raised $60 million in fresh funding, following another year of growth.
16 Jul 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Neuraxpharm and Dizlin announce co-development agreement
Neuraxpharm and Dizlin Pharmaceuticals has announced a strategic global co-development agreement for Infudopa SubC.
15 Jul 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
PCI Pharma Services receives strategic investment
PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company.
15 Jul 2025
Pharma Manufacturing News + Pharma Finance and Investment News
DHL opens new facility in Dublin
DHL Supply Chain announces the opening of a new multi-user facility in Dublin, as part of the €637 million investment into the UK & Ireland region.
14 Jul 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Siemens recognition for Bürkert enables improved development
Fluid control specialist Bürkert has become an official Siemens Product Partner for Siemen’s SIMATIC Automation Systems.
11 Jul 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Aggreko highlights potential for BESS to increase efficiency
In the face of volatile energy pricing and grid instability, Aggreko is highlighting the potential for battery energy storage systems (BESS) and battery hybrids to help increase resilience and on-site efficiency.
11 Jul 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00